TRETIVA 30 CAPSULES
| Product Name | TRETIVA 30 Capsules |
| Active Ingredient | Isotretinoin |
| Strength | 30 mg |
| Form | Oral Capsules |
| Pack Size | Strip of Capsules (as per manufacturer) |
| Usage | Treatment of severe acne |
| Administration | Oral, with food, as prescribed |
| Storage | Store below 25Β°C in a dry place |
TRETIVA 30 CAPSULES
TRETIVA 30 Capsules are an oral medication containing isotretinoin, a vitamin A derivative used to treat severe, stubborn acne that does not respond to other treatments. It works by reducing oil (sebum) production in the skin, preventing clogged pores, and limiting the growth of acne-causing bacteria. Dermatologists often prescribe TRETIVA 30 Capsules for nodular or cystic acne to help achieve clearer, healthier skin.
This medication also reduces skin inflammation and promotes faster healing of acne lesions, helping prevent permanent acne scars. TRETIVA 30 Capsules are usually taken once or twice daily with food, as directed by a doctor. Treatment duration varies based on acne severity and patient response. With proper medical supervision, TRETIVA 30 Capsules can significantly improve skin condition.
TRETIVA 30 Capsules are used under medical guidance because isotretinoin may cause side effects and is not safe during pregnancy. Regular blood tests and doctor checkups are important during treatment. Patients should follow all medical advice, avoid excess alcohol, and use sunscreen while on therapy. When used correctly, these capsules provide effective long-term acne control and help maintain clearer skin.
Product Features
- Contains isotretinoin for severe acne treatment
- Reduces oil production in the skin
- Prevents clogged pores and acne breakouts
- Helps reduce inflammation and acne scars
- Doctor-recommended therapy for resistant acne
How It Helps
- Controls excess sebum production
- Clears severe cystic and nodular acne
- Reduces acne-causing bacteria
- Prevents new pimples from forming
- Improves overall skin clarity and texture

Reviews
There are no reviews yet.